Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
52%
OVERLAP
BY WEIGHT
17
# OF OVERLAPPING
HOLDINGS
FBT
31
HOLDINGS
57%
ALSO IN PBE
PBE
28
HOLDINGS
61%
ALSO IN FBT
SECTOR DRIFT (FBT minus PBE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 4.2% | 4.6% | 4.2% |
|
AMGEN INC | 4.1% | 4.8% | 4.1% |
|
VERTEX PHARMACEUTICALS INC | 3.7% | 4.9% | 3.7% |
|
UNITED THERAPEUTICS CORP | 3.6% | 3.7% | 3.6% |
|
BIOGEN IDEC INC | 3.5% | 5.5% | 3.5% |
FBT Overweight Relative to PBE
|
MODERNA, INC. | 5.3% |
 |
BIONTECH SE SPONSORED ADR | 3.8% |
|
KRYSTAL BIOTECH, INC. | 3.6% |
 |
ALKERMES PLC | 3.5% |
 |
ARGENX SE ADR | 3.3% |
|
CORCEPT THERAPEUTICS INC | 3.3% |
|
BEIGENE LTD. SPONSORED ADR | 3.2% |
|
NATERA INC | 3.0% |
 |
GENMAB A/S SPONSORED ADR | 2.9% |
|
ALNYLAM PHARMACEUTICALS INC | 2.9% |
FBT Underweight Relative to PBE
|
ROYALTY PHARMA PLC CLASS A | -4.7% |
|
IONIS PHARMACEUTICALS, INC. | -4.2% |
|
PTC THERAPEUTICS INC | -3.4% |
|
CATALYST PHARMACEUTICAL PART | -2.7% |
|
MADRIGAL PHARMACEUTICALS, INC. | -2.7% |
|
DYNAVAX TECHNOLOGIES CORP | -2.5% |
|
AKEBIA THERAPEUTICS INC | -2.3% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -2.3% |
|
VERICEL CORPORATION | -2.3% |
|
BIOCRYST PHARMACEUTICALS INC | -2.1% |